Cargando…

Self-expanding metal stents for the palliation of malignant gastric outlet obstruction in patients with peritoneal carcinomatosis

AIM: To evaluate the efficacy of self-expanding metal stents (SEMS) for the palliation of malignant gastric outlet obstruction in patients with and without peritoneal carcinomatosis (PC). METHODS: We performed a retrospective analysis of 62 patients who underwent SEMS placement for treatment of mali...

Descripción completa

Detalles Bibliográficos
Autores principales: Rademacher, Christoph, Bechtler, Matthias, Schneider, Steffen, Hartmann, Bettina, Striegel, Johannes, Jakobs, Ralf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5116599/
https://www.ncbi.nlm.nih.gov/pubmed/27920476
http://dx.doi.org/10.3748/wjg.v22.i43.9554
_version_ 1782468690239815680
author Rademacher, Christoph
Bechtler, Matthias
Schneider, Steffen
Hartmann, Bettina
Striegel, Johannes
Jakobs, Ralf
author_facet Rademacher, Christoph
Bechtler, Matthias
Schneider, Steffen
Hartmann, Bettina
Striegel, Johannes
Jakobs, Ralf
author_sort Rademacher, Christoph
collection PubMed
description AIM: To evaluate the efficacy of self-expanding metal stents (SEMS) for the palliation of malignant gastric outlet obstruction in patients with and without peritoneal carcinomatosis (PC). METHODS: We performed a retrospective analysis of 62 patients who underwent SEMS placement for treatment of malignant gastroduodenal obstruction at our hospital over a six-year period. Stents were deployed through the scope under combined fluoroscopic and endoscopic guidance. Technical success was defined as successful stent placement and expansion. Clinical success was defined as an improvement in the obstructive symptoms and discharge from hospital without additional parenteral nutrition. According to carcinomatosis status, patients were assigned into groups with or without evidence of peritoneal disease. RESULTS: In most cases, obstruction was caused by pancreatic (47%) or gastric cancer (23%). Technical success was achieved in 96.8% (60/62), clinical success in 79% (49/62) of all patients. Signs of carcinomatosis were identified in 27 patients (43.5%). The diagnosis was confirmed by pathology or previous operation in 7 patients (11.2%) and suspected by CT, MRI or ultrasound in 20 patients (32.2%). Presence of carcinomatosis was associated with a significantly lower clinical success rate compared to patients with no evidence of peritoneal disease (66.7% vs 88.6%, P = 0.036). There was no significant difference in overall survival between patients with or without PC (median 48 d vs 70 d, P = 0.21), but patients showed significantly longer survival after clinical success of SEMS placement compared to those experiencing clinical failure (median 14.5 d vs 75 d, P = 0.0003). CONCLUSION: Given the limited therapeutic options and a clinical success rate of at least 66.7%, we believe that SEMS are a reasonable treatment option in patients with malignant gastric outlet obstruction with peritoneal carcinomatosis.
format Online
Article
Text
id pubmed-5116599
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-51165992016-12-05 Self-expanding metal stents for the palliation of malignant gastric outlet obstruction in patients with peritoneal carcinomatosis Rademacher, Christoph Bechtler, Matthias Schneider, Steffen Hartmann, Bettina Striegel, Johannes Jakobs, Ralf World J Gastroenterol Retrospective Study AIM: To evaluate the efficacy of self-expanding metal stents (SEMS) for the palliation of malignant gastric outlet obstruction in patients with and without peritoneal carcinomatosis (PC). METHODS: We performed a retrospective analysis of 62 patients who underwent SEMS placement for treatment of malignant gastroduodenal obstruction at our hospital over a six-year period. Stents were deployed through the scope under combined fluoroscopic and endoscopic guidance. Technical success was defined as successful stent placement and expansion. Clinical success was defined as an improvement in the obstructive symptoms and discharge from hospital without additional parenteral nutrition. According to carcinomatosis status, patients were assigned into groups with or without evidence of peritoneal disease. RESULTS: In most cases, obstruction was caused by pancreatic (47%) or gastric cancer (23%). Technical success was achieved in 96.8% (60/62), clinical success in 79% (49/62) of all patients. Signs of carcinomatosis were identified in 27 patients (43.5%). The diagnosis was confirmed by pathology or previous operation in 7 patients (11.2%) and suspected by CT, MRI or ultrasound in 20 patients (32.2%). Presence of carcinomatosis was associated with a significantly lower clinical success rate compared to patients with no evidence of peritoneal disease (66.7% vs 88.6%, P = 0.036). There was no significant difference in overall survival between patients with or without PC (median 48 d vs 70 d, P = 0.21), but patients showed significantly longer survival after clinical success of SEMS placement compared to those experiencing clinical failure (median 14.5 d vs 75 d, P = 0.0003). CONCLUSION: Given the limited therapeutic options and a clinical success rate of at least 66.7%, we believe that SEMS are a reasonable treatment option in patients with malignant gastric outlet obstruction with peritoneal carcinomatosis. Baishideng Publishing Group Inc 2016-11-21 2016-11-21 /pmc/articles/PMC5116599/ /pubmed/27920476 http://dx.doi.org/10.3748/wjg.v22.i43.9554 Text en ©The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Retrospective Study
Rademacher, Christoph
Bechtler, Matthias
Schneider, Steffen
Hartmann, Bettina
Striegel, Johannes
Jakobs, Ralf
Self-expanding metal stents for the palliation of malignant gastric outlet obstruction in patients with peritoneal carcinomatosis
title Self-expanding metal stents for the palliation of malignant gastric outlet obstruction in patients with peritoneal carcinomatosis
title_full Self-expanding metal stents for the palliation of malignant gastric outlet obstruction in patients with peritoneal carcinomatosis
title_fullStr Self-expanding metal stents for the palliation of malignant gastric outlet obstruction in patients with peritoneal carcinomatosis
title_full_unstemmed Self-expanding metal stents for the palliation of malignant gastric outlet obstruction in patients with peritoneal carcinomatosis
title_short Self-expanding metal stents for the palliation of malignant gastric outlet obstruction in patients with peritoneal carcinomatosis
title_sort self-expanding metal stents for the palliation of malignant gastric outlet obstruction in patients with peritoneal carcinomatosis
topic Retrospective Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5116599/
https://www.ncbi.nlm.nih.gov/pubmed/27920476
http://dx.doi.org/10.3748/wjg.v22.i43.9554
work_keys_str_mv AT rademacherchristoph selfexpandingmetalstentsforthepalliationofmalignantgastricoutletobstructioninpatientswithperitonealcarcinomatosis
AT bechtlermatthias selfexpandingmetalstentsforthepalliationofmalignantgastricoutletobstructioninpatientswithperitonealcarcinomatosis
AT schneidersteffen selfexpandingmetalstentsforthepalliationofmalignantgastricoutletobstructioninpatientswithperitonealcarcinomatosis
AT hartmannbettina selfexpandingmetalstentsforthepalliationofmalignantgastricoutletobstructioninpatientswithperitonealcarcinomatosis
AT striegeljohannes selfexpandingmetalstentsforthepalliationofmalignantgastricoutletobstructioninpatientswithperitonealcarcinomatosis
AT jakobsralf selfexpandingmetalstentsforthepalliationofmalignantgastricoutletobstructioninpatientswithperitonealcarcinomatosis